A detailed history of Macquarie Group LTD transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 582,320 shares of INSP stock, worth $108 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
582,320
Previous 592,056 1.64%
Holding current value
$108 Million
Previous $79.2 Million 55.11%
% of portfolio
0.14%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$125.79 - $216.71 $1.22 Million - $2.11 Million
-9,736 Reduced 1.64%
582,320 $123 Million
Q2 2024

Aug 09, 2024

BUY
$133.83 - $251.19 $4.49 Million - $8.43 Million
33,571 Added 6.01%
592,056 $79.2 Million
Q1 2024

May 14, 2024

BUY
$165.3 - $226.0 $3.29 Million - $4.5 Million
19,910 Added 3.7%
558,485 $120 Million
Q4 2023

Feb 14, 2024

SELL
$125.26 - $203.83 $8.15 Million - $13.3 Million
-65,031 Reduced 10.77%
538,575 $110 Million
Q3 2023

Nov 14, 2023

BUY
$185.0 - $326.08 $5.97 Million - $10.5 Million
32,279 Added 5.65%
603,606 $120 Million
Q2 2023

Aug 14, 2023

SELL
$226.52 - $324.64 $6.28 Million - $9.01 Million
-27,740 Reduced 4.63%
571,327 $185 Million
Q1 2023

May 15, 2023

SELL
$229.06 - $278.01 $106 Million - $128 Million
-461,605 Reduced 43.52%
599,067 $140 Million
Q4 2022

Feb 21, 2023

SELL
$164.02 - $259.76 $57 Million - $90.2 Million
-347,241 Reduced 24.66%
1,060,672 $267 Million
Q3 2022

Nov 14, 2022

SELL
$170.68 - $226.46 $22.6 Million - $30 Million
-132,582 Reduced 8.61%
1,407,913 $250 Million
Q2 2022

Aug 15, 2022

BUY
$147.53 - $266.6 $2.07 Million - $3.74 Million
14,017 Added 0.92%
1,540,495 $281 Million
Q1 2022

May 16, 2022

BUY
$193.94 - $261.91 $38.2 Million - $51.6 Million
196,945 Added 14.81%
1,526,478 $392 Million
Q4 2021

Feb 11, 2022

BUY
$207.57 - $280.17 $53.3 Million - $71.9 Million
256,762 Added 23.93%
1,329,533 $306 Million
Q3 2021

Nov 12, 2021

BUY
$170.0 - $258.58 $130 Million - $197 Million
762,866 Added 246.16%
1,072,771 $250 Million
Q2 2021

Aug 13, 2021

BUY
$164.93 - $242.23 $40 Million - $58.8 Million
242,689 Added 361.06%
309,905 $59.9 Million
Q1 2021

May 14, 2021

SELL
$182.45 - $249.25 $2.73 Million - $3.73 Million
-14,951 Reduced 18.2%
67,216 $13.9 Million
Q4 2020

Feb 16, 2021

SELL
$119.35 - $200.46 $2.1 Million - $3.52 Million
-17,569 Reduced 17.62%
82,167 $15.5 Million
Q3 2020

Nov 13, 2020

SELL
$87.5 - $130.91 $1.53 Million - $2.29 Million
-17,461 Reduced 14.9%
99,736 $12.9 Million
Q2 2020

Aug 11, 2020

SELL
$49.5 - $97.93 $840,807 - $1.66 Million
-16,986 Reduced 12.66%
117,197 $10.2 Million
Q1 2020

May 15, 2020

SELL
$41.62 - $89.92 $116,203 - $251,056
-2,792 Reduced 2.04%
134,183 $8.09 Million
Q4 2019

Feb 14, 2020

BUY
$52.12 - $75.0 $583,066 - $839,025
11,187 Added 8.89%
136,975 $10.2 Million
Q3 2019

Nov 14, 2019

SELL
$61.02 - $70.19 $15,438 - $17,758
-253 Reduced 0.2%
125,788 $7.68 Million
Q2 2019

Aug 14, 2019

BUY
$47.07 - $60.71 $2.17 Million - $2.79 Million
46,026 Added 57.52%
126,041 $7.64 Million
Q1 2019

May 15, 2019

BUY
$39.48 - $62.0 $1.97 Million - $3.1 Million
50,015 Added 166.72%
80,015 $4.54 Million
Q3 2018

Nov 15, 2018

BUY
$36.8 - $56.99 $1.1 Million - $1.71 Million
30,000 New
30,000 $1.26 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.34B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.